Although NTN1 was initially reported to be downregulated in NB [17], a more recent clinical study revealed that NB tissues from stage-4 patients exhibited an overexpression of NTN1, conferring a selective advantage for survival of NB cells. The gene discussed is NTN1; the disease is neuroblastoma.